The Changing COVID-19 Landscape: A Feasibility Study to Capture Momentary Residential Environmental Exposures and Asthma Sypmtoms in Adults
不断变化的 COVID-19 形势:捕捉瞬时居住环境暴露和成人哮喘症状的可行性研究
基本信息
- 批准号:10369705
- 负责人:
- 金额:$ 21.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-15 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressAdolescentAdultAdvocateAffectAirAir PollutantsAreaAsthmaBehaviorCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 preventionCellular PhoneChemical ExposureChemicalsChicagoChildCommunicable DiseasesCommunitiesComplexComputer softwareDataData CollectionData ReportingDeath RateDiagnosisDirect CostsDisease OutbreaksDisinfectantsEcological momentary assessmentEconomic BurdenElderlyEnvironmental ExposureEnvironmental ImpactEnvironmental MonitoringEnvironmental Risk FactorExposure toFaceFacilities and Administrative CostsFeasibility StudiesFrequenciesFutureGoalsHandHomeHome environmentHourHouseholdHousingHygieneIndividualIndoor Air QualityIndoor environmentInterventionMeasuresMidwestern United StatesMonitorNotificationNursesParticipantParticulateParticulate MatterPatient Self-ReportPhysiciansPopulationPreventive measurePublic HealthPulmonary Function Test/Forced Expiratory Volume 1Quality-Adjusted Life YearsReadinessRecommendationReportingResearchRespiratory DiseaseRisk FactorsRisk ReductionScheduleScientistSelf ManagementShelter facilitySpirometrySurveysSymptomsTimeUnited StatesVirusVirus Diseasesage groupasthma exacerbationbasechronic respiratory diseasecostdesigneconomic impactenvironmental tobacco smokeexperiencefine particleshealth economicsimprovedinnovationmemberpandemic coronaviruspandemic diseasepollutantpulmonary functionrecruitsensorusabilityvolatile organic compoundwillingness
项目摘要
ABSTRACT
The global pandemic of coronavirus 2019 (COVID-19) is a substantial cause for concern among individuals
with chronic respiratory diseases, including those with asthma. It is estimated that more than 60% of adults
with asthma have uncontrolled symptoms and this represents a substantial health and economic impact.
Compared to children, adults are nearly five times more likely to die from asthma and the asthma-related
death rate is highest among those 65 years and older. Viral infections are a prominent risk factor for
asthma exacerbation and, thus, SARS-CoV-2, the virus responsible for COVID-19, is cause for alarm among
those diagnosed with asthma. Sheltering-in-place orders and recommendations, physical distancing, wearing
face coverings, hand hygiene, and increased cleaning and disinfecting are primary COVID-19 preventative
measures advocated. The effects of home-based strategies to prevent COVID-19, specifically increased
residential exposure to cleaning/disinfecting agents and particulates on adults with asthma is unknown. Our
long term goal is to characterize the impact of COVID-19 on existing asthma risk factors so as to develop
tailored, home-based asthma interventions that adequately acknowledge COVID-19 and are responsive to the
changing home environment and home routines resulting from this pandemic. The aims of this study are: 1)
determine the feasibility and usability of: (a) ecological momentary assessment (EMA) to assess self-report
residential environmental exposures and asthma symptoms, (b) home monitoring of objective environmental
exposures (total volatile organic compounds [VOCs], particulates [PM2.5]), and lung function (home spirometry);
2a) assess the frequency and degree of residential environmental exposures (e.g., disinfectants/cleaners,
second-hand smoke) via (a) self-reported data, and (b) home monitoring objective measures, 2b) assess the
level of asthma control as indicated by self-reported asthma symptoms and lung function; and 3) explore
associations of self-reported and objective measures of residential environmental exposures with self-reported
and objective measures of asthma control. We will recruit 50 adults with asthma who completed our ongoing
online COVID-19 and asthma survey, indicated willingness to be contacted for future studies, reported high
use of disinfectant/cleaning products, and have not-well controlled asthma. Participants will receive an indoor
air quality monitor and a home spirometer to measure VOCs, PM2.5, and FEV1% respectively. EMA will be
collected using a personal smartphone and EMA software platform. Participants’ will be sent scheduled and
random EMA notifications to assess asthma symptoms, environmental exposures, lung function, and mitigation
strategies. After the 14-day data collection period, participants will respond to survey items related
acceptability, appropriateness, and feasibility. Findings from this feasibility study will support a powered study
to address the impact of environmental exposures related to COVID-19 and to enhance preparedness for
future infectious disease outbreaks by developing innovative intervention strategies for those with asthma.
抽象的
2019 年冠状病毒 (COVID-19) 的全球大流行是引起个人担忧的重要原因
据估计,超过 60% 的成年人患有慢性呼吸道疾病,包括哮喘。
哮喘患者的症状不受控制,这对健康和经济产生了重大影响。
与儿童相比,成人死于哮喘的可能性高出近五倍,而与哮喘相关的疾病
65 岁及以上人群的死亡率最高,病毒感染是一个重要的危险因素。
哮喘恶化,因此 SARS-CoV-2(导致 COVID-19 的病毒)引起了人们的警惕
被诊断患有哮喘的人 就地避难的命令和建议、保持身体距离、穿着。
面罩、手部卫生以及加强清洁和消毒是主要的 COVID-19 预防措施
提倡的居家策略的效果尤其显着增强。
患有哮喘的成人在住宅中接触清洁/消毒剂和颗粒物的情况尚不清楚。
长期目标是确定 COVID-19 对现有哮喘危险因素的影响,以便制定
量身定制的、以家庭为基础的哮喘干预措施,充分认识到 COVID-19 并响应
这次流行病导致的家庭环境和家庭日常生活的改变本研究的目的是:1)
确定以下方面的可行性和可用性: (a) 生态瞬时评估(EMA)以评估自我报告
居住环境暴露和哮喘症状,(b) 客观环境的家庭监测
暴露(总挥发性有机化合物 [VOC]、颗粒物 [PM2.5])和肺功能(家庭肺活量测定);
2a) 评估住宅环境暴露的频率和程度(例如消毒剂/清洁剂、
二手烟)通过 (a) 自我报告数据,以及 (b) 家庭监测客观措施,2b) 评估
自我报告的哮喘症状和肺功能表明哮喘控制水平;3) 探索
住宅环境暴露的自我报告和客观测量与自我报告的关联
我们将招募 50 名完成我们正在进行的哮喘治疗的成年人。
在线 COVID-19 和哮喘调查,表明愿意联系未来的研究,报告高
使用消毒剂/清洁产品且哮喘控制不佳的参与者将接受室内治疗。
空气质量监测仪和家用肺活量计分别测量 VOC、PM2.5 和 FEV1%。
使用个人智能手机和 EMA 软件平台收集的信息将按计划发送。
随机 EMA 通知评估哮喘症状、环境暴露、肺功能和缓解情况
在 14 天的数据收集期结束后,参与者将对相关的调查项目做出回应。
该可行性研究的可接受性、适当性和可行性将支持有力的研究。
解决与 COVID-19 相关的环境暴露的影响并加强应对准备
通过为哮喘患者制定创新的干预策略来应对未来传染病的爆发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kamal M Eldeirawi其他文献
Kamal M Eldeirawi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kamal M Eldeirawi', 18)}}的其他基金
The Changing COVID-19 Landscape: A Feasibility Study to Capture Momentary Residential Environmental Exposures and Asthma Sypmtoms in Adults
不断变化的 COVID-19 形势:捕捉瞬时居住环境暴露和成人哮喘症状的可行性研究
- 批准号:
10250681 - 财政年份:2021
- 资助金额:
$ 21.97万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Reducing Vaccine Hesitancy among Hispanic Parents of COVID-19 Vaccine-Eligible Children
减少有资格接种 COVID-19 疫苗的儿童的西班牙裔家长对疫苗的犹豫
- 批准号:
10737776 - 财政年份:2023
- 资助金额:
$ 21.97万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10568736 - 财政年份:2022
- 资助金额:
$ 21.97万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10895221 - 财政年份:2022
- 资助金额:
$ 21.97万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10708938 - 财政年份:2022
- 资助金额:
$ 21.97万 - 项目类别:
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)
识别儿童多系统炎症综合征 (MIS-C) 预后价值的生物标志物特征
- 批准号:
10320491 - 财政年份:2021
- 资助金额:
$ 21.97万 - 项目类别: